Intrinsic Bioprobes Inc. Launches Three New CLIA Approved Mass Spectrometry-Based Tests for Proteins Implicated in Kidney Disease and Renal Failure
4/20/2011 7:43:43 AM
More...
|
Intrinsic Bioprobes Inc. Announces Issuance of US Patent for Novel Biomarkers and Assays for Myocardial Infarction
10/27/2010 7:38:43 AM
More...
|
Intrinsic Bioprobes Inc. Announces the Discovery and Exclusive Licensing of Novel Biomarkers for Diabetes
1/21/2010 9:33:26 AM
More...
|
Intrinsic Bioprobes Inc. Enters into a $1.27M Contract with the National Cancer Institute to Develop Multiplex Mass Spectrometric Immunoassays for Detection of Low Abundance Cancer-Related Proteins
3/31/2009 8:38:05 AM
More...
|
Intrinsic Bioprobes Inc. Release: Novel Mass Spectrometry-based Assay Reveals Degradation and Low Levels of Bioactive B-type Natriuretic Peptide (BNP) in Patients with Heart Failure
10/17/2008 8:11:48 AM
More...
|